Skip to main content
KyungdongPharm logo

KyungdongPharm — Investor Relations & Filings

Ticker · 011040 ISIN · KR7011040003 KO Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2024-02-16 Notice of Dividend Amou…
Country KR South Korea
Listing KO 011040

About KyungdongPharm

https://kdpharma.co.kr

KyungdongPharm is a pharmaceutical company engaged in the development, manufacturing, and distribution of medicines. Since its establishment in 1975, the company has focused on producing a broad portfolio of specialized therapeutic drugs and general pharmaceuticals. Its product lines encompass prescription medicines, with a focus on areas such as liver therapy, and over-the-counter products, including its prominent painkiller brand, 'Geunal-N'. The company also manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates. Utilizing advanced production facilities and proprietary technology, KyungdongPharm is dedicated to developing high-quality medicines supported by clinical research to contribute to public health.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Kyungdong Pharmaceutical regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend record date, the payment date, and the approval body (Board of Directors). This fits the definition of a 'Notice of Dividend Amount' (DIV).
2024-02-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Kyungdong Pharmaceutical. It outlines the date, location, and agenda items (approval of financial statements, election of directors, and remuneration limits). This type of document is a standard proxy solicitation/notice of meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-02-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Kyungdong Pharm) announcing a significant change (over 15%) in revenue or profit structure. This is a standard disclosure requirement for listed companies in Korea to report preliminary financial results before the final audit is completed. Since it provides key financial highlights and reasons for the change rather than being a full annual report or a simple announcement of a report's availability, it falls under the category of an Earnings Release (ER). FY 2023
2024-02-15 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing a 'Decision to Acquire Treasury Shares' (자기주식 취득 결정). This document outlines the company's plan to buy back its own shares, including the number of shares, the purpose (shareholder value enhancement), and the method. According to the provided filing definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2024-01-30 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific disposal of 8,000 treasury shares to employees, including the date, price, and the resulting change in the company's treasury share holdings. This falls under the category of a company reporting its own share transactions (buybacks or disposals).
2024-01-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details specific share transactions (purchases) made by an executive (Ryu Deok-hee) of Kyungdong Pharmaceutical. This type of filing is a standard regulatory disclosure for insider trading/director dealings.
2024-01-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.